Max Healthcare Institute (NSE:MAXHEALTH) Other Current Receivables: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MAXHEALTH Max Healthcare Institute Ltd NSE:MAXHEALTH
93 GF Score
Price ₹1,005.00
GF Value ₹1,437.55
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Max Healthcare Institute Other Current Receivables?

Max Healthcare Institute NSE:MAXHEALTH -1.08% 93 Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:MAXHEALTH with a GF Score™ of 93/100 and a GF Value™ of ₹1,437.55 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Max Healthcare Institute's Other Current Receivables for the quarter that ended in Jun. 2026 was ₹0 Mil.

Max Healthcare Institute's annual Other Current Receivables increased from Mar. 2024 (₹443.10 Mil) to Mar. 2025 (₹715.00 Mil) but then declined from Mar. 2025 (₹715.00 Mil) to Mar. 2026 (₹709.70 Mil).

Max Healthcare Institute Other Current Receivables Related Terms

Max Healthcare Institute Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Max Healthcare Institute's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Max Healthcare Institute Other Current Receivables Chart

Max Healthcare Institute Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 361.40 336.40 443.10 715.00 709.70

Max Healthcare Institute Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 709.70 0.00
NSE:MAXHEALTH
93GF Score
Max Healthcare Institute Ltd NSE:MAXHEALTH
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Max Healthcare Institute Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹0 Mil mean?
Max Healthcare Institute (NSE:MAXHEALTH) has a Other Current Receivables of ₹0 Mil as of Jun. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Max Healthcare Institute and its competitors.
Is Max Healthcare Institute's Other Current Receivables too high?
Max Healthcare Institute's current Other Current Receivables is ₹0 Mil. Overall, Max Healthcare Institute has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Max Healthcare Institute's Other Current Receivables compare to HCA and THC?
Max Healthcare Institute's Other Current Receivables of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Healthcare Providers & Services company?
A good Other Current Receivables depends on the Healthcare Providers & Services industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Max Healthcare Institute and its competitors. Max Healthcare Institute's current Other Current Receivables is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Max Healthcare Institute stock overvalued right now?
Based on GuruFocus' analysis, Max Healthcare Institute (NSE:MAXHEALTH) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,437.55, compared to a current price of ₹1,005.00 — trading 30.1% below its estimated fair value. The current Other Current Receivables is ₹0 Mil. Max Healthcare Institute's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Max Healthcare Institute (NSE:MAXHEALTH), the current Other Current Receivables is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Max Healthcare Institute (NSE:MAXHEALTH) Overvalued in 2026?

Based on GuruFocus' analysis, Max Healthcare Institute stock appears to be undervalued. The current stock price of ₹1,005.00 is trading 30.1% below its estimated GF Value™ of ₹1,437.55. GuruFocus considers Max Healthcare Institute to be Significantly Undervalued.

Key valuation signals for NSE:MAXHEALTH:

  • Other Current Receivables: ₹0 Mil
  • GF Value™: ₹1,437.55 vs. price of ₹1,005.00 (30.1% below fair value)
  • GF Score™: 93/100 with 1 warning sign

No single metric tells the full story. See the NSE:MAXHEALTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Max Healthcare Institute Business Description

Other Exchanges 543220:India
Address Capital Cyberscape, Sector-59, 2nd Floor, Gurugram, HR, IND, 122 102
Max Healthcare Institute Ltd is a health care service provider. The company's facilities include third-party healthcare providers with whom the company has entered long-term service contracts for providing clinical, radiology, and pathology services. Its hospitals provide the full range of services through its Outpatient, Day Care, Emergency Room, and In-Patient departments to accommodate medical specialties such as orthopedics, internal medicine, general surgery, cardiac sciences, oncology, neurosciences, and obstetrics, as well as diagnostics. The group derives revenue from India.
93GF Score

Get the complete analysis for NSE:MAXHEALTH

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,005.00
Price
₹1,437.55
GF Value